The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of neoadjuvant treatment for HER2 positive early-stage breast cancer.
 
Hiten Naik
No Relationships to Disclose
 
Karen A. Gelmon
Honoraria - AstraZeneca; Merck Sharp & Dohme; Novartis Canada Pharmaceuticals Inc; Seagen
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Bristol-Myers Squibb; Genomic Health; Janssen Oncology; Lilly; Merck; Mylan; NanoString Technologies; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche (Inst)
Expert Testimony - Genentech
 
Lovedeep Gondara
No Relationships to Disclose
 
Rekha M. Diocee
No Relationships to Disclose
 
Caroline Speers
No Relationships to Disclose
 
Rinat Yerushalmi
Honoraria - AstraZeneca; Novartis; Pfizer; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Research Funding - Roche
 
Caroline A. Lohrisch
Consulting or Advisory Role - AstraZeneca Canada
 
Nathalie LeVasseur
Consulting or Advisory Role - Knight Pharmaceuticals; Lilly; Novartis Canada Pharmaceuticals Inc; Pfizer; TerSera
Research Funding - Abbvie; Exact Sciences; Genomic Health